Newsletter Subject

Beware this OTC treatment for acid reflux -- carries cancer risk

From

malehealthcures.com

Email Address

matt@malehealthcures.com

Sent On

Wed, May 20, 2020 09:23 PM

Email Preheader Text

Whatever you do, do NOT use this antacid... PS. This also naturally lowers cholesterol -- ----------

Whatever you do, do NOT use this antacid... [Can't see this image? Click on 'load images' or 'always allow images for this sender'] ----Important Message---- Protocol C2T increases men’s metabolic rate and boosts testosterone Believe it or not, there’s a natural factory process that goes on in a man’s testicles to make testosterone. And when you use my new Protocol C2T, it’s like hiring more workers for this testosterone factory… Your metabolic rate increases and that increases testosterone production in the testicles. And soon you’re enjoying naturally high testosterone levels in the 800s like me! [Discover Protocol C2T here for free and naturally raise your testosterone.]( PS. This also naturally lowers cholesterol -- [here’s how...]( ---------- Beware this OTC treatment for acid reflux -- carries cancer risk One of the things that drives me the most crazy about Big Pharma is that there is very little long-term follow-up on treatments once they are approved for market. This is the case even though the risk of things such as cancer and cardiovascular disease can take more than a decade to show up. What makes this worse is that many of the most profitable treatments that Big Pharma sells are meds that people take every single day – sometimes for decades. It’s completely irresponsible not to have further follow-up studies. [Can't see this image? Click on 'load images' or 'always allow images for this sender'] Yet that is the way it goes. The FDA is being pretty casual about some of this. You may have seen in the news that Zantac (a treatment for acid reflux) poses a cancer risk because of potential contamination by a carcinogen called N-nitrosodimethylamine (NDMA). This triggered a recall in many other countries, but not in the United States. Instead, the FDA simply said on September 13 of 2019: “The US Food and Drug Administration has learned that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.” This statement tries to make people feel better about the risk by burying it in other data. However, the risk still exists. Then on September 24 they issued a VOLUNTARY recall in the US: “The US Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz Inc., used to decrease the amount of acid created by the stomach. This recall is due to a nitrosamine impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled medicine. NDMA is classified as a probable human carcinogen (a substance that could cause cancer).” Voluntary recalls mean that they don’t deem the threat serious enough to make it a mandatory recall – and that this medicine may still be selling in the US. To me, this is alarming because the FDA seems to be favoring the profits of Big Pharma over the health of consumers. That is NOT good. The Zantac voluntary recall is only the tip of the iceberg. The real problem here is that this very casual attitude toward a problem with Zantac is only the tip of the iceberg. There are tons of other medicines on the market that pose a VERY real cancer risk. You can hear the disclaimers on TV ads for biologic treatments that are used to treat rheumatoid arthritis. [Can't see this image? Click on 'load images' or 'always allow images for this sender'] Here is part of the disclaimer from Humira: “Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers, including HUMIRA. Postmarketing cases of hepatosplenic T-cell lymphoma (HSTCL), a rare type of T-cell lymphoma, have been reported in patients treated with TNF blockers, including HUMIRA. These cases have had a very aggressive disease course and have been fatal.” This alarming information in the ads is usually covered up by smiling people and happy music... Because Big Pharma doesn’t want you to think about the bad side effects of these drugs. There are tons more examples of this. But the big thing is that you consider ALL of your risks before you take anything – and don’t assume it’s safe. The bottom line... There are many treatments on the market that come with black-box cancer risks. And my guess is that there are even more that pose cardiovascular, cancer, or diabetes risks that we just don’t know about because there aren’t enough rigorous studies done. As with anything else, you have to decide if the risk is worth the potential upside. I can’t answer that for you. But knowing your risks, reading the information on the treatment pamphlet, and deciding if the treatment is right for you can help you make better decisions about your health. ----Important Message---- $1.63 a day method does more good for prostate than any pill Even top doctors are STUNNED... As it's not just one of those temporary solutions that fails you when you need it the most... It actually treats the root cause of prostate problems...which is a "DHT clog"... And once you slash the DHT clog, you get rid of ALL your prostate problems in less than 5 days! [The miraculous treatment is laid out on this page, so you can start using it right now.]( ---------- Daily Medical Discoveries is dedicated to uncovering secret, buried or censored studies that can help men live great lives to 120 and beyond. You are subscribed because you joined one of our lists by opting in. We never rent or share your email address. Daily Medical Discoveries is published by Calworth Glenford LLC which also publishes other affiliated companies. By giving us your email address, you consent for Daily Medical Discoveries and its affiliated companies to delivering you a healthy daily portion of email issues and advertisements. To end your email subscription and associated external offers sent from Daily Medical Discoveries, feel free to [click here]( FREE BOOK: As a Daily Medical Discoveries subscriber in good standing, you’re eligible to receive a FREE book containing underground, buried and ignored remedies that help men live a happy, healthy and sexy life to 120 years old, including specific help for men who want more sex, more life and more of everything. [Click here to claim your copy.]( Comments / Questions? You can hit REPLY to this email or email me, Matt, at matt@getrapidhelp.com Missing issues? How to make sure you NEVER miss an issue! The real key is CLICKING and OPENING emails. That shows your email provider (Yahoo, Gmail or whoever) that you WANT our email. If you don’t click or open, you won’t be getting them anymore, sadly. BIG TIP: Hit REPLY and say “Hi Matt” or ask a question, and THAT will assure your email provider that you want our emails! Copyright © 2020 Calworth Glenford LLC, 1005 Country Club Av., Cheyenne WY 82001 USA. Publication without written permission from Calworth Glenford is strictly prohibited. Please - you are in charge of your own life. We’re not saying “don’t see a doctor.” We’re presenting research. Don’t hold us responsible if you do something as a result of what you read here. Life’s all an experiment, none of us have the answers, but the more hidden/secret/censored/ignored information you have, the better off you are. We aren’t doctors, and we aren’t giving you personal health or sex advice! If you email us with personal information, it is our policy that we forbid our employees from sharing anything you tell us with outside parties, except if you give us permission to share it, or we are compelled by force of law to share it. Daily Medical Discoveries or its affiliated companies accept third party advertisements which will be labeled “sponsored”, “third party sponsored”, etc. Third party advertising helps pay the high costs of our newsletters through various business arrangements including commissions. We try to accept advertising only from legitimate advertisers, but you bear all responsibility in dealing directly with them and will not hold us responsible. Sometimes, Daily Medical Discoveries or its affiliated companies sell their own products or services and will solicit your business for those. These solicitations are NOT third party advertisements. We can stand behind anything you buy in full accord with our terms and conditions of sale, for whatever product or service you purchase.

Marketing emails from malehealthcures.com

View More
Sent On

22/08/2022

Sent On

22/08/2022

Sent On

21/08/2022

Sent On

21/08/2022

Sent On

20/08/2022

Sent On

20/08/2022

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.